Bharat Biotech International Limited is an Indian multinational biotechnology company headquartered in Hyderabad, engaged in the drug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products. Read More
External Affairs Minister Dr S Jaishankar on Wednesday welcomed the World Health Organisation (WHO)'s decision to grant approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin. ...
Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin has received an extension of shelf life for up to 12 months from the date of manufacturing on Wednesday by India's pharmaceuticals and medical regulatory body. ...
The World Health Organisation (WHO), has granted approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin. ...
Two days after World Health Organisation (WHO) sought additional clarifications for emergency use listing of Bharat Biotech's vaccine Covaxin, Foreign Secretary Harsh Vardhan Shringla on Thursday said that the government is carefully following the d ...
Reacting to World Health Organisation (WHO) seeking additional clarifications for emergency use listing of Bharat Biotech's Covid-19 vaccine Covaxin, Professor of Centre for Community Medicine (CCM) in All India Institute of Medical Sciences (AIIMS) ...
World Health Organisation (WHO) official Dr Margaret Harris has said that the decision on Bharat Biotech's COVID-19 vaccine Covaxin's emergency use listing recommendation is expected within 24 hours. ...
